vs
Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $47.7M, roughly 2.0× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -98.1%, a 93.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -47.3%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -20.2%).
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
HIVE vs IRWD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $47.7M |
| Net Profit | $-91.3M | $-2.3M |
| Gross Margin | -27.1% | — |
| Operating Margin | — | 14.3% |
| Net Margin | -98.1% | -4.8% |
| Revenue YoY | 218.6% | -47.3% |
| Net Profit YoY | -234.0% | -200.9% |
| EPS (diluted) | $-0.38 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.1M | $47.7M | ||
| Q3 25 | $87.3M | $122.1M | ||
| Q2 25 | $45.6M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $29.2M | $90.5M | ||
| Q3 24 | $22.6M | $91.6M | ||
| Q2 24 | $32.2M | $94.4M | ||
| Q1 24 | — | $74.9M |
| Q4 25 | $-91.3M | $-2.3M | ||
| Q3 25 | $-15.8M | $40.1M | ||
| Q2 25 | $35.0M | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | $68.2M | $2.3M | ||
| Q3 24 | $80.0K | $3.6M | ||
| Q2 24 | $-18.3M | $-860.0K | ||
| Q1 24 | — | $-4.2M |
| Q4 25 | -27.1% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | -13.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -43.7% | — | ||
| Q3 24 | -66.1% | — | ||
| Q2 24 | -7.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 61.8% | ||
| Q2 25 | — | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | — | 26.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | -98.1% | -4.8% | ||
| Q3 25 | -18.1% | 32.8% | ||
| Q2 25 | 76.8% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | 233.2% | 2.5% | ||
| Q3 24 | 0.4% | 4.0% | ||
| Q2 24 | -56.7% | -0.9% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | $-0.38 | $0.01 | ||
| Q3 25 | $-0.07 | $0.23 | ||
| Q2 25 | $0.18 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $0.52 | $0.03 | ||
| Q3 24 | $0.00 | $0.02 | ||
| Q2 24 | $-0.17 | $-0.01 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $559.3M | $-261.8M |
| Total Assets | $624.0M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $40.5M | $88.6M | ||
| Q3 24 | $31.7M | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $559.3M | $-261.8M | ||
| Q3 25 | $624.6M | $-264.2M | ||
| Q2 25 | $560.5M | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | $430.9M | $-301.3M | ||
| Q3 24 | $275.5M | $-311.3M | ||
| Q2 24 | $268.6M | $-321.7M | ||
| Q1 24 | — | $-330.5M |
| Q4 25 | $624.0M | $396.9M | ||
| Q3 25 | $693.0M | $396.1M | ||
| Q2 25 | $628.7M | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | $478.6M | $350.9M | ||
| Q3 24 | $334.7M | $389.5M | ||
| Q2 24 | — | $395.6M | ||
| Q1 24 | — | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.0M | $74.6M | ||
| Q3 25 | $-10.6M | $47.6M | ||
| Q2 25 | $10.2M | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | $-28.5M | $15.2M | ||
| Q3 24 | $-2.2M | $9.9M | ||
| Q2 24 | $-4.4M | $33.5M | ||
| Q1 24 | — | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | $-55.5M | — | ||
| Q3 24 | $-34.7M | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | -189.9% | — | ||
| Q3 24 | -153.4% | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 92.5% | 0.0% | ||
| Q3 24 | 143.9% | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 0.29× | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.42× | 6.74× | ||
| Q3 24 | -26.94× | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
